Pharmaceutical marketing: Implications for medical residency training

Pharmacotherapy

Volumn 16, Issue 1 I, 1996, Pages 103-107

  Anastasio, Geraldine D ^a,b   Little Jr , John M ^b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; DRUG INFORMATION; DRUG MARKETING; GENERAL PRACTICE; HUMAN; MEDICAL DECISION MAKING; RESIDENCY EDUCATION;

DRUG INDUSTRY; FAMILY PRACTICE; INTERNSHIP AND RESIDENCY; INTERVIEWS; MARKETING OF HEALTH SERVICES;

EID: 0030040925     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Shaughnessy AF, Hume AL. Clinical pharmacists in family practice residency programs J Fam Pract 1990;31:305-9.
2. Manning PR, Denson TA. How internists learned about cimetidine. Ann Intern Med 1980;92.690-2.
3. Hume AL, Shaughnessy AF. Sources of influence on the prescribing practices of residents in family medicine. DICP Ann Pharmacother 1991;25:102-3.
4. Hagood WJ, Owen JA. The image of the drug industry, as seen from town and gown. Va Med Monogr 1967,94:110-14
5. Lurie N, Rich EC, Simpson DE, et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med 1990;5.240-3.
6. Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives JAMA 1995,273 1296-8
7. Avorn J, Soumeri SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing." N Engl J Med 1983;308:1457-63
8. Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making JAMA 1990;263:549-56.
9. Shaughnessy AF. Drug promotion in a family medicine training center JAMA 1988;260.926.
10. Goodfriend TL. Using pharmaceutical advertising in medical education. Acad Med 1991;66:122.
11. Ferguson RP. Training the resident to meet the detail man. JAMA 1989;261.992-3.
12. Chren MM, Landefeld CS, Murray TH. Doctors, drug companies, and gifts. JAMA 1989;262:3448-51
13. Council on Ethical and Judicial Affairs of the American Medical Association. Gifts to physicians from industry. JAMA 1991,165:501.
14. Hemminki E. Content analysts of drug detailing by pharmaceutical representatives Med Educ 1977;11:210-15.
15. Kessler DA, Pines WL. The federal regulation of prescription drug advertising and promotion. JAMA 1990;264:2409-15.
16. Levy R. The role and value of pharmaceutical marketing. Arch Fam Med 1994,3;327-32.
17. Shaughnessy AF, Slawson DC, Bennett JH. Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion. J Gen Intern Med 1994;9:563-8.
18. Sigmon JL, Anastasio GD. The drug sample closet J Fam Pract 1992;34:262-3.
19. Ives T, Anastasio GD. Ambulatory drug therapy. In Sloane PD, Slatt LM, Curtis P, eds Essentials of family medicine Baltimore: Williams & Wilkins, 1993:103-10
20. Miller LG, Blum A. Physician awareness of prescription drug costs: a missing element of drug advertising and promotion. J Fam Pract 1993;36:33-6.
21. Snedecor GW, Cochran WG. Statistical methods Ames, IA: Iowa University Press, 1967.